EP-1676: Sparing potential of scanned protons for the treatment of intramammary nodes in breast radiotherapy  by Dasu, A. et al.
ESTRO 35 2016                                                                                                                                                    S783 
________________________________________________________________________________ 
Most of the patients have been treated for acute leukemia 
with allogeneic transplant. 
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Purpose or Objective: Breast cancer patients are among the 
long-term survivors of radiotherapy and therefore the long-
term cardiopulmonary toxicity due to the treatment should 
be reduced to a minimum. However, complication rates could 
be further increased when intramammary nodes are included 
in the target due to their proximity to the heart and the 
lungs. Several techniques could be used to decrease the dose 
to the normal tissues and consequently the rates of late 
complications, including proton beam radiotherapy and 
respiratory gating. This study aims to investigate the 
potential for normal tissue sparing for the treatment of 
intramammary nodes in breast cancer radiotherapy using 
scanned proton beams with or without respiratory gating. 
 
Material and Methods: The study was performed on CT-
datasets acquired from ten left-sided patients during 
enhanced inspiration gating (EIG) and free-breathing (FB). 
The patients were planned with intensity modulated proton 
therapy (IMPT) for locoregional breast treatment. The 
prescribed dose to the target was 50 GyRBE in 25 fractions, 
assuming an RBE of 1.1. Different plans were performed for 
breast and supraclavicular nodes respectively breast, 
supraclavicular and intramammary nodes (IMN). The 
implications of including IMN in the target volume were 
evaluated from the point of view of the doses to the organs 
at risk for cardiopulmonary complications. 
 
Results: Inclusion of the IMN in the target volume led to a 
small increase of the cardiopulmonary burden. Thus, in FB 
cases the average dose to the heart increased from 0.3 to 0.4 
GyRBE and the average dose to the lung increased from 6.1 
to 6.6 GyRBE, while the average dose to the left anterior 
descending artery (LAD) decreased from 4.1 to 3.8 GyRBE. 
For EIG cases the average dose to the heart was almost 
unchanged (0.2 GyRBE), the average dose to the lung 
increased from 6.9 to 7.4 GyRBE and the average dose to the 
LAD decreased from 3.3 to 2.6 GyRBE. Other dosimetric 
parameters of interest showed a similar trend when IMN were 
included in the target. These parameters are much lower 
than those that could be achieved in conventional 
radiotherapy with photons, especially with respect to the 
cardiovascular burden, irrespective of whether respiratory 
gating is used or not. 
 
Conclusion: The results of this study indicate that 
radiotherapy with scanned proton beams has the potential of 
significantly limit the cardiopulmonary burden compared to 
photon RT when including the IMN in breast cancer 
radiotherapy. 
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Purpose or Objective: Stereotactic ablative radiotherapy 
(SABR) for the lung primary and metastatic tumors aims to 
increase the local control, survival and quality of life. Deep 
inspiration breath hold (DIBH) using 4D CT for simulation 
minimizes respiratory motion and reduces the toxicity risk by 
decreasing margins. In this study, we aimed to compare the 
dosimetric results of different devices and techniques of 
SABR using volumetric arc therapy (VMAT) with DIBH in the 
lung tumors. 
 
Material and Methods: CT datasets of 7 patients with right-
sided lung cancer performed with RPM system (Varian, Palo 
Alto) was used. Median PTV was 13.2cc. Dose prescription 
objective was to cover 98% of the target volume by D98% 
which was 50 Gy/5 fractions. Four different VMAT plans were 
made on Eclipse TPS (Varian, Palo Alto) using AAA algorithm. 
Plan A consisted of TrueBeam,120HDMLC, 6MV-FFF, without 
jaw tracking, Plan B TrueBeam,120HDMLC, 6MV-FFF, with jaw 
tracking, Plan C TrueBeam,120HDMLC, 6MV, without jaw 
tracking, Plan D with Trilogy, 120MilleniumMLC, 6MV, without 
jaw tracking. Three partial arcs using 210 degrees were used 
to generate the plans under the same optimization 
conditions. Monitor Unit (MU), beam-on time (BOT), Gradient 
Index (GI), lung V20 and V5, dose at 2 cm from PTV (D2cm), 
PTV(Dmax) and PTV(Dmin) were assessed for comparison. 
Wilcoxon test was used for statistical evaluation. 
 
Results: No statistically significant differences were found 
for total MU, D2cm and PTV(Dmin) between the four plans. 
Mean PTV(Dmax) values were lower in Plan C with HDMLC 
compared to Plan D with MilleniumMLC (122.9%±3.9 vs 
126.8%±3.7, p=.018). At GI assessment; there was no 
significant difference between plans with and without jaw-
tracking. However, there was a significant difference 
between Plan C and Plan D (4.4±0.5 vs 4.8±0.6, p=.018); and 
between Plan A (FFF) and Plan C (FF) (4.2±0.4 vs 4.4±0.5, 
p=.018). V20 and V5 was lower in Plan C compared to Plan D 
(2.8%±1.5 vs 3.3%±1.5, p=.028 and 15.1%±5.3 vs 16.0%±5.6, 
p=.018).; V5 was lower in Plan A compared to Plan C 
(14.4%±5.1% vs 15.1%±5.3). BOT was significantly shorter 
between Plan A and Plan C (167.5 sec±20.4 vs 390.5 
sec±47.8, p=.018). 
 
Conclusion: In SABR with WMAT using DIBH, we observed 
some improvements by using HDMLC compared to 
MilleniumMLC and FFF compared to FF beams. However, we 
could not observe additional benefit with jaw tracking in the 
FFF mode. Major advantage of FFF was the shorter BOT, 
which may finally improve the patient compliance in SABR 
using DIBH technique. 
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Purpose or Objective: In locally advanced NSCLC Concurrent 
chemo/Radiation is the key most important treatment 
approach. However delivering adequate radiation dose to 
improve treatment results is limited by the tolerance of 
nearby structures (lungs, esophagus, heart etc…), and by the 
intrafractional uncertainties resulting from prolonged 
treatment time of the conventional techniques. We have 
compared VMATplanes Vs. 3D CRT in inoperable advanced 
lung cancer cases. 
 
Material and Methods: Ten cases of previously treated lung 
cancer with 3DCRT planes ( minimum of 4 beams) were 
replanned with VMAT optimization using 2 half arcs. Both 
planes were performed on Eclipse© planning system (version 
11) with AAA-algorithm and linear accelerator UNIQUE © of 
energy 6Mv , dose rate of 600 cGy/min , and 120 multileaf 
collimator. The dose was prescribed as 60Gy / 30fr to the 
CTV surrounded with margin of 1.5cm for the PTV. Plans 
were compared for coverage , avoidance of organs at risk , 
and total number of MU. 
 
